SCHEMBL25848383

SCHEMBL25848383

C=CC(=O)OCC(F)(F)OC(F)(F)OC(F)(F)OC(F)(F)COc1ccc2cc(-c3ccc(OC)cc3C)c(=O)oc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
MAOB P27338 8/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 2/20 0.41
HPGD P15428 2/20 0.41
CA12 O43570 1/20 0.41
CA2 P00918 1/20 0.41
GLA P06280 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625409 0.91 NPC1 (0.42) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL22625326 0.90 NPC1 (0.41) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL25848384 0.89 NPC1 (0.45) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL25848367 0.88 NPC1 (0.42) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL25848335 0.88 NPC1 (0.44) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL25848378 0.87 THRB (0.39) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL25848195 0.87 NPC1 (0.46) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL25848241 0.85 NPC1 (0.42) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL22625079 0.85 RAB9A (0.42) NPC1RAB9AMAOBKDM4EALDH1A1
SCHEMBL22624981 0.84 NPC1 (0.53) NPC1RAB9AKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 NPC1 1051/4885RAB9A 1916/4885MAOB 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.